Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06536101
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-26
Brief Title:
The Purpose of the Study is to Evaluate the Safety Tolerability and Pharmacokinetics of Single-ascending and Multiple-ascending Doses of GIM-407
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 First-in-human Randomized Double-blind Placebo-controlled Single and Multiple Ascending Dose Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of GIM-407 in Healthy Adult Participants
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is for the evaluation of the safety tolerability PK PD and biomarker activity of GIM-407 in healthy volunteers in the absence of any disease-related or potentially confounding factors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None